GeoVax Labs (OTCMKTS:GOVX)

GeoVax Labs (OTCMKTS:GOVX)


Share Price
$ 0.02
Change
-0.00075 (-3.41 %)
Market Cap
$4.18 m
Proactive Investors - Run By Investors For Investors

GeoVax Labs

GeoVax Labs, Inc. (OTCBB: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using our novel DNA/MVA platform technology. Our platform supports production of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine.  Producing VLPs in the person being vaccinated mimics a natural infection,...

EPIC: GOVX
Market: OTCQB:GOVX
52-week High/Low: $0.05 / $0.02
Sector: Pharmaceuticals
Market Cap: $4.18M
Website: www.geovax.com
col 3
col 4
col 5
col 6

GeoVax Labs Timeline

Newswire

GeoVax Labs records SIV risk cuts

GeoVax Labs records a 76% reduction in per exposure risk of simian immunodeficiency virus (SIV) infection in young adult rhesus macaques
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use